Tango Therapeutics, Inc. Taxes Payable, Current
Tango Therapeutics, Inc. (TNGX) had Taxes Payable, Current of $35.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2024-03-18
- 2023-03-31: Taxes Payable, Current $35.00K.
- 2022-12-31: Taxes Payable, Current $35.00K.
- 2022-06-30: Taxes Payable, Current $1.00K.
- 2022-03-31: Taxes Payable, Current $52.00K.
| Period end | Taxes Payable, Current |
|---|---|
| 2023-03-31 | $35.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $35.00K 10-K · filed 2024-03-18 |
| 2022-06-30 | $1.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $52.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $52.00K 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |